Beyond Inhalers: The Era of Biologics in COPD

Recorded: September 3, 2025

The treatment landscape for COPD is rapidly evolving. With the emergence of biologic therapies targeting type 2 inflammation, clinicians now have new opportunities to personalize treatment for patients who continue to experience exacerbations despite optimized inhaled therapy. In this webinar, speakers review the evolving role of type 2 inflammation in COPD, the latest evidence supporting biologic therapies, and practical strategies for identifying the right treatment for patients.

This webinar is brought to you by the CHEST Airways Disorders Network’s Asthma and COPD Section.